Overview

Update
Total Equity Funding
$5.5M in 2 Rounds from 5 Investors
Most Recent Funding
$2M Series A on August 17, 2015
Headquarters:
Menlo Park, CA
Description:
NuMedii discovers and de-risks effective drugs by translating life sciences big data into therapies.
Founders:
, ,
Categories:
Biotechnology
Website:
http://numedii.com
Social:

Company Details

Update

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.

Funding Rounds (2) - $5.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2015$2M / Series A5
Jun, 2013$3.5M / Series A2

Current Team (6)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    PO Box 7381

    Menlo Park, CA 94026

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos